For patients with COVID-19 who are at high risk for severe disease and/or hospitalization, the FDA has authorized monoclonal antibody (mAb) treatments.
Our bodies naturally make antibodies to fight infection, but that takes time. And for some patients, the body can’t make antibodies fast enough to fight COVID-19. Monoclonal antibody treatments can provide the body with a way to protect itself sooner.
Don’t wait. Here’s what you can do right now.
Call your doctor ASAP.
COVID-19 can get worse quickly, so the moment you test positive, ask your healthcare provider if you're eligible for monoclonal antibody treatment.
Discover mAb treatment options.
Monoclonal antibodies could help certain patients with COVID-19 avoid hospitalization. But they must be administered soon after your patient is diagnosed COVID-19 positive.
COVID FRONTLINE RESOURCE CENTER
Healthcare professionals, patients and caregivers can now access a robust COVID-19 resource center. It features guidance on where to be treated, prevention and treatment strategies, educational animations and videos, up-to-the-minute information and interactive tools.Visit Now